ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023)
ENDRA Life Sciences (NDRA) posted quarterly Short term Debt of $28484.0 for Q4 2023, little changed YoY from $28484.0 in Q4 2022, and little changed sequentially from $28484.0 in Q3 2023.
ENDRA Life Sciences (NDRA) Short term Debt (2022 - 2023) Analysis & Trends
ENDRA Life Sciences has disclosed Short term Debt across 2 years of filings, most recently posting $28484.0 for Q4 2023.
- In Q4 2023, Short term Debt changed 0.0% year-over-year to $28484.0; the TTM figure through Dec 2023 stood at $28484.0 (changed 0.0% YoY), while the FY2023 annual figure was $28484.0, changed 0.0% from the prior year.
- Short term Debt held at $28484.0 in Q4 2023, from $28484.0 in the prior quarter.
- Over the last five years, Short term Debt for NDRA reached as high as $28484.0 in Q4 2022 and fell as low as $28484.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28,484.00 |
| Sep 30, 2023 | 28,484.00 |
| Jun 30, 2023 | 28,484.00 |
| Dec 31, 2022 | 28,484.00 |